We are live on
!
Find out more
B
Bellecapital Portfolio holdings
AUM
$625M
1-Year Est. Return
39.69%
This Fund
S&P 500
This Quarter
Est. Return
-0.93%
1 Year Est. Return
+39.69%
3 Year Est. Return
+127.77%
5 Year Est. Return
+155.51%
10 Year Est. Return
+530.97%
AUM
$91.3M
AUM Growth
+$16.5M
(+22%)
Cap. Flow
+$16.5M
Cap. Flow
% of AUM
18.03%
Top 10 Holdings %
Top 10 Hldgs %
48.93%
Holding
71
New
20
Increased
16
Reduced
6
Closed
4
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Biotechnology ETF
IBB
|
+$5.9M |
| 2 |
Cooper Companies
COO
|
+$4.06M |
| 3 |
State Street SPDR S&P International Small Cap ETF
GWX
|
+$2.05M |
| 4 |
Alphabet (Google) Class C
GOOG
|
+$1.33M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$813K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
ExxonMobil
XOM
|
+$1.5M |
| 2 |
iShares International Developed Real Estate ETF
IFGL
|
+$1.34M |
| 3 |
PIMCO Enhanced Short Maturity Active Exchange-Traded Fund
MINT
|
+$404K |
| 4 |
iShares MSCI Europe Financials ETF
EUFN
|
+$303K |
| 5 |
WisdomTree Europe Hedged Equity Fund
HEDJ
|
+$204K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 41.15% |
| 2 | Technology | 12.58% |
| 3 | Communication Services | 11.48% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Healthcare | 9.78% |
Similar funds
TAM
RIP
CWM
LWP
FGA
BVC
APM
PIM
Bellecapital's Q2 2016 Portfolio in Review
As of Q2 2016, Bellecapital held 71 positions worth $91.3M, up 22% from $74.8M the previous quarter. Its ten largest holdings account for 49% of the portfolio.
Bellecapital deployed $16.5M of net new capital in Q2 2016, opening 20 new positions and adding to 16 existing holdings. Its largest new stake was iShares Biotechnology ETF: 65,787 shares worth $5.64M.
By sector, the portfolio is most concentrated in Miscellaneous at 41% of assets, down from 43% a quarter earlier, followed by Technology and Communication Services.
On the sell side, the largest reduction was ExxonMobil, an estimated $1.5M trimmed.
- Bellecapital's largest Q2 2016 buy was iShares Biotechnology ETF: 65,787 shares worth $5.64M.
- Bellecapital added most to Apple in Q2 2016, an estimated $782K increase.
- Bellecapital's biggest Q2 2016 reduction was ExxonMobil, cutting an estimated $1.5M.
- Bellecapital fully exited iShares International Developed Real Estate ETF in Q2 2016, selling an estimated $1.34M.
- Bellecapital's ten largest holdings make up 49% of its $91.3M portfolio in Q2 2016.
- Bellecapital opened 20 new positions and closed 4 in Q2 2016.
- Bellecapital's portfolio value rose 22% quarter-over-quarter to $91.3M.
Based on Bellecapital's 13F filing for Q2 2016, filed 11 Aug 2016.